Literature DB >> 28477188

Polarizing Cytokines for Human Th9 Cell Differentiation.

Prabhakar Putheti1.   

Abstract

CD4+ T helper (Th) cell subset generation in vivo requires T cell receptor activation and surface CD28 co-stimulation in the presence of one or more cytokines. Similarly, Th cells can be generated in vitro by activating naïve CD4+CD25- T cells with plate bound-anti-CD3 monoclonal antibody (mAb) (pbCD3) and soluble-anti-CD28 mAb (sCD28) in the presence of polarizing recombinant (r) cytokines and anti-cytokine mAbs. In comparison to in vitro CD4+CD25- T cells, memory CD4+CD25-CD45RO+ T cells have been shown to convert to Th9 cells more efficiently. Here, protocol for in vitro generation of human Th9 cells by activating CD4+CD25-CD45RO+ memory T cells with pbCD3 and sCD28 in the presence of polarizing recombinant interleukin-4 (rIL-4) and transforming growth factor (rTGF-β) is described.

Entities:  

Keywords:  Human Th9 cells; IL-4; IL-9; Peripheral blood; T Helper cells; TGF-β

Mesh:

Substances:

Year:  2017        PMID: 28477188     DOI: 10.1007/978-1-4939-6877-0_6

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

Review 1.  The Love-Hate Relationship Between TGF-β Signaling and the Immune System During Development and Tumorigenesis.

Authors:  Baode Chen; Chenglin Mu; Zhiwei Zhang; Xuelin He; Xia Liu
Journal:  Front Immunol       Date:  2022-05-26       Impact factor: 8.786

Review 2.  HLA-Class II Artificial Antigen Presenting Cells in CD4+ T Cell-Based Immunotherapy.

Authors:  Alexandre Couture; Anthony Garnier; Fabian Docagne; Olivier Boyer; Denis Vivien; Brigitte Le-Mauff; Jean-Baptiste Latouche; Olivier Toutirais
Journal:  Front Immunol       Date:  2019-05-17       Impact factor: 7.561

3.  TGF-β1 Drives Inflammatory Th Cell But Not Treg Cell Compartment Upon Allergen Exposure.

Authors:  Stephanie Musiol; Francesca Alessandrini; Constanze A Jakwerth; Adam M Chaker; Evelyn Schneider; Ferdinand Guerth; Benjamin Schnautz; Johanna Grosch; Ileana Ghiordanescu; Julia T Ullmann; Josephine Kau; Mirjam Plaschke; Stefan Haak; Thorsten Buch; Carsten B Schmidt-Weber; Ulrich M Zissler
Journal:  Front Immunol       Date:  2022-01-07       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.